Linus Angenendt
16PUBLICATIONS
54CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (16)
Sort by Publication Date:
|Mar 08, 2024
Epigenetic control over the cell-intrinsic immune response antagonizes self-renewal in acute myeloid leukemia.Eloísa Felipe Fumero, Carolin Walter, Joris Maximillian Frenz
|Feb 26, 2024
Prevalence and clinical impact of CD56 and T-cell marker expression in acute myeloid leukaemia: A single-centre retrospective analysis.Inna Shaforostova, Simon Call, Georg Evers
|Nov 15, 2023
Deep learning predicts therapy-relevant genetics in acute myeloid leukemia from Pappenheim-stained bone marrow smears.Jacqueline Kockwelp, Sebastian Thiele, Jannis Bartsch
|Nov 03, 2022
Revisiting coexisting chromosomal abnormalities in NPM1-mutated AML in light of the revised ELN 2022 classification.Linus Angenendt, Christoph Röllig, Pau Montesinos
|Apr 25, 2022
Using stroma-anchoring cytokines to augment ADCC: a phase 1 trial of F16IL2 and BI 836858 for posttransplant AML relapse.Andrew F Berdel, Leo Ruhnke, Linus Angenendt
|Sep 24, 2021
Calcitonin receptor-like (CALCRL) is a marker of stemness and an independent predictor of outcome in pediatric AML.Linus Angenendt, Marius Wöste, Jan-Henrik Mikesch
Pageof 3
Frequent Collaborators
5 joint publications
Wolfgang E Berdel
3 joint publications
Wolfgang Hartmann
2 joint publications
Martin Dugas
2 joint publications
Carsten Müller-Tidow
2 joint publications
Christoph Röllig
2 joint publications
Christian Récher
2 joint publications
Andrew F Berdel
2 joint publications
Hubert Serve
1 joint publications
Stefan K Bohlander
1 joint publications
Kirsten M Knecht
